{"id":"W2099826019","doi":"10.1016/s0140-6736(11)60936-7","title":"Rilpivirine versus efavirenz with tenofovir and emtricitabine in treatment-naive adults infected with HIV-1 (ECHO): a phase 3 randomised double-blind active-controlled trial","year":2011,"lang":"en","type":"article","venue":"The Lancet","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":401,"is_retracted":false,"has_abstract":false,"ca_institutions":"University Health Network","funders":"International AIDS Society","keywords":"Rilpivirine; Emtricitabine; Efavirenz; Medicine; Viral load; Internal medicine; Regimen; Reverse-transcriptase inhibitor; Virology; Pharmacology; Human immunodeficiency virus (HIV); Antiretroviral therapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002319108,0.0004074871,0.001375711,0.0002143702,0.0001008483,0.00002433323,0.0001074762,0.00008157972,0.0001395129],"category_scores_gemma":[0.00005074505,0.0001872731,0.00008264666,0.0004265694,0.0001423769,0.000121173,0.00002581807,0.0002010703,0.00003214587],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001789537,"about_ca_system_score_gemma":0.0002459815,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001470627,"about_ca_topic_score_gemma":0.0003915778,"domain_scores_codex":[0.9984156,0.0001273209,0.0003520634,0.0004027548,0.0002562103,0.0004460006],"domain_scores_gemma":[0.9988072,0.0003291304,0.0001927476,0.0004404851,0.00007993884,0.0001504779],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9814925,0.002216834,0.005314439,0.00001937132,0.001496028,0.0002961685,0.004827822,9.287592e-7,0.00006442307,0.00002128442,0.0001287012,0.004121461],"study_design_scores_gemma":[0.9850644,0.00726831,0.004011121,0.0001517355,0.001074572,0.00003448331,0.0002541348,0.0000710157,0.001453648,0.00001027563,0.0003683144,0.0002379742],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9816163,0.00012452,0.00001830767,0.001103602,0.00006853828,0.007016103,0.00002524371,0.00009475607,0.009932601],"genre_scores_gemma":[0.9941392,0.00014956,0.0005907067,0.0000564788,0.0003165981,0.001538291,0.0001266573,0.000039254,0.003043267],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01252286,"threshold_uncertainty_score":0.7636777,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04770636682178646,"score_gpt":0.2973200934542903,"score_spread":0.2496137266325038,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}